VNDA
Vanda Pharmaceuticals Inc
5.00$
-1.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1.1% | +0.7% | -0.2% | -1.0% | +1.7% | -3.7% | -1.1% | -3.8% | -18.7% | -11.3% | -4.9% | |
| – | -19.3% | +1.5% | -0.1% | -1.5% | +1.5% | -7.1% | -3.2% | -6.9% | -5.5% | -15.6% | -9.8% | |
| – | -25.9% | -7.9% | -17.7% | -2.4% | +1.8% | +9.3% | -27.6% | -13.5% | +21.2% | -36.3% | +3.4% | |
| – | -20.7% | +1.5% | -1.6% | -2.9% | -0.4% | -9.0% | -4.5% | -9.8% | -10.2% | -23.3% | -16.0% | |
| – | +16.7% | +7.5% | +14.0% | +2.1% | +10.2% | -5.3% | +0.9% | +12.3% | +8.0% | +4.2% | +4.9% | |
| – | +34.9% | +10.9% | -2.4% | +9.9% | +6.9% | +11.4% | +12.8% | -5.9% | -9.3% | -8.3% | -1.2% | |
| – | +596.4% | -1.7% | -1.5% | -1.5% | -1.5% | -1.5% | -1.6% | -1.6% | +7.6% | -1.7% | -1.7% | |
| – | +5.1% | +5.0% | +0.2% | -4.6% | +13.3% | +2.4% | +14.9% | -2.4% | +19.7% | -5.6% | +25.9% | |
| – | +3.4% | +6.4% | +0.5% | -5.0% | +12.2% | +3.9% | +16.9% | -3.0% | +23.2% | -6.6% | +21.0% | |
| – | +1.0% | +0.5% | +0.7% | +1.2% | +74.0% | +2.9% | +6.5% | +0.2% | +18.5% | +8.4% | -23.1% | |
| – | +104.8% | -7.9% | -42.6% | +53.8% | -39.8% | +71.2% | -63.6% | +44.0% | +57.3% | -9.5% | +94.2% | |
| – | +0.3% | -0.2% | -0.3% | -0.2% | -0.5% | -5.0% | -4.9% | -4.2% | -29.8% | -14.2% | -21.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.1% | +0.4% | +0.8% | +0.1% | +0.1% | +0.4% | +0.8% | -0.2% | +0.4% | +0.6% | +1.3% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.